Virginia Commonwealth University
Richmond, Virginia, 23298, United States
NCT Number: NCT00110630
The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.
Looking for future studies?
Notify Me18 year–100 year
Female
Interventional
Phase 3
Richmond, Virginia, 23298, United States
This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeNational Institute on Drug Abuse (NIDA)
Nih
Smoking Treatment of Prisoners: Project "STOP"
Acronym: STOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT00136812
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT04768114
Behavior, Chemically-Induced Disorders
St Louis, Missouri, United States
View Trial DetailsNCT03626064
Behavior, Chemically-Induced Disorders
View Trial Details